Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
8.89
+0.34 (3.98%)
Nov 18, 2026, 4:00 PM EST - Market closed
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $271.79 million as of November 18, 2026. It is the 18,630th most valuable company in the world and the 3,271st biggest in the United States. Its market cap has increased by 163.73% in one year.
Market Cap
271.79M
Enterprise Value
267.66M
1-Year Change
163.73%
Global Rank
Country Rank
#3,271 United States
Category
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $271.79M, an increase of 38.56%. That is a compound annual growth rate of 34.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 271.79M | 134.27% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Greenwich LifeSciences | 274.48M |
| TRex Bio | 269.22M |
| Precision BioSciences | 269.10M |
| PepGen | 268.73M |
| SAB Biotherapeutics | 265.76M |
| Q32 Bio | 258.24M |
| Allogene Therapeutics | 257.81M |
| Ocugen | 256.75M |